Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2007 6
2008 13
2009 11
2010 11
2011 13
2012 8
2013 9
2014 6
2015 5
2016 9
2017 12
2018 9
2019 8
2020 9
2021 9
2022 8
2023 11
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R. The EMPA-KIDNEY Collaborative Group, et al. N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4. N Engl J Med. 2023. PMID: 36331190 Free PMC article. Clinical Trial.
Effect of Treating Hyperphosphatemia With Lanthanum Carbonate vs Calcium Carbonate on Cardiovascular Events in Patients With Chronic Kidney Disease Undergoing Hemodialysis: The LANDMARK Randomized Clinical Trial.
Ogata H, Fukagawa M, Hirakata H, Kagimura T, Fukushima M, Akizawa T; LANDMARK Investigators and Committees. Ogata H, et al. JAMA. 2021 May 18;325(19):1946-1954. doi: 10.1001/jama.2021.4807. JAMA. 2021. PMID: 34003226 Free PMC article. Clinical Trial.
The Authors Reply.
Komaba H, Taniguchi M, Wada A, Iseki K, Tsubakihara Y, Fukagawa M. Komaba H, et al. Kidney Int. 2015 Sep;88(3):638-9. doi: 10.1038/ki.2015.218. Kidney Int. 2015. PMID: 26323075 Free article. No abstract available.
Phosphate-a poison for humans?
Komaba H, Fukagawa M. Komaba H, et al. Kidney Int. 2016 Oct;90(4):753-63. doi: 10.1016/j.kint.2016.03.039. Epub 2016 Jun 7. Kidney Int. 2016. PMID: 27282935 Free article. Review.
Resurgence of parathyroidectomy: evidence and outcomes.
Komaba H, Nakamura M, Fukagawa M. Komaba H, et al. Curr Opin Nephrol Hypertens. 2017 Jul;26(4):243-249. doi: 10.1097/MNH.0000000000000326. Curr Opin Nephrol Hypertens. 2017. PMID: 28375871 Review.
Etelcalcetide for the treatment of secondary hyperparathyroidism.
Hamano N, Komaba H, Fukagawa M. Hamano N, et al. Among authors: komaba h. Expert Opin Pharmacother. 2017 Apr;18(5):529-534. doi: 10.1080/14656566.2017.1303482. Epub 2017 Mar 15. Expert Opin Pharmacother. 2017. PMID: 28277829 Review.
143 results